Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.
Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with bipolar disorders or schizophrenia Developed plans for TRANQUILITY...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0385 | -12.03125 | 0.32 | 0.3399 | 0.266 | 2063471 | 0.30344767 | CS |
| 4 | -0.0885 | -23.9189189189 | 0.37 | 0.437 | 0.266 | 3152521 | 0.33758123 | CS |
| 12 | -0.3458 | -55.1251394867 | 0.6273 | 0.63 | 0.266 | 1744573 | 0.38776606 | CS |
| 26 | -0.7185 | -71.85 | 1 | 1.04 | 0.266 | 1045080 | 0.45729545 | CS |
| 52 | -3.3085 | -92.1587743733 | 3.59 | 4.17 | 0.266 | 1041980 | 1.42662388 | CS |
| 156 | -15.3285 | -98.196668802 | 15.61 | 34.125 | 0.266 | 1110701 | 6.93394866 | CS |
| 260 | -20.3685 | -98.6368038741 | 20.65 | 74.89 | 0.266 | 853403 | 14.14157236 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
